<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="cytoa24509" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cytometry A</journal-id><journal-id journal-id-type="iso-abbrev">Cytometry A</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">CYTO</journal-id><journal-title-group><journal-title>Cytometry</journal-title></journal-title-group><issn pub-type="ppub">1552-4922</issn><issn pub-type="epub">1552-4930</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9543383</article-id><article-id pub-id-type="pmcid-ver">PMC9543383.1</article-id><article-id pub-id-type="pmcaid">9543383</article-id><article-id pub-id-type="pmcaiid">9543383</article-id><article-id pub-id-type="pmid">34668313</article-id><article-id pub-id-type="doi">10.1002/cyto.a.24509</article-id><article-id pub-id-type="publisher-id">CYTOA24509</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Omip</subject></subj-group><subj-group subj-group-type="heading"><subject>Omip</subject></subj-group></article-categories><title-group><article-title>
<styled-content style="fixed-case" toggle="no">OMIP</styled-content>&#8208;079: Cell cycle of <styled-content style="fixed-case" toggle="no">CD4</styled-content>
<sup>+</sup> and <styled-content style="fixed-case" toggle="no">CD8</styled-content>
<sup>+</sup> na&#239;ve/memory T cell subsets, and of Treg cells from mouse spleen</article-title><alt-title alt-title-type="left-running-head">Natalini et al.</alt-title></title-group><contrib-group><contrib id="cytoa24509-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Natalini</surname><given-names initials="A">Ambra</given-names></name><xref rid="cytoa24509-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>ambra.natalini@ibpm.cnr.it</email></address></contrib><contrib id="cytoa24509-cr-0002" contrib-type="author"><name name-style="western"><surname>Simonetti</surname><given-names initials="S">Sonia</given-names></name><xref rid="cytoa24509-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cytoa24509-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cytoa24509-curr-0001" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib id="cytoa24509-cr-0003" contrib-type="author"><name name-style="western"><surname>Favaretto</surname><given-names initials="G">Gabriele</given-names></name><xref rid="cytoa24509-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24509-cr-0004" contrib-type="author"><name name-style="western"><surname>Peruzzi</surname><given-names initials="G">Giovanna</given-names></name><xref rid="cytoa24509-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cytoa24509-cr-0005" contrib-type="author"><name name-style="western"><surname>Antonangeli</surname><given-names initials="F">Fabrizio</given-names></name><xref rid="cytoa24509-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24509-cr-0006" contrib-type="author"><name name-style="western"><surname>Santoni</surname><given-names initials="A">Angela</given-names></name><xref rid="cytoa24509-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cytoa24509-cr-0007" contrib-type="author"><name name-style="western"><surname>Mu&#241;oz&#8208;Ruiz</surname><given-names initials="M">Miguel</given-names></name><xref rid="cytoa24509-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="cytoa24509-cr-0008" contrib-type="author"><name name-style="western"><surname>Hayday</surname><given-names initials="A">Adrian</given-names></name><xref rid="cytoa24509-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><xref rid="cytoa24509-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><xref rid="cytoa24509-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="cytoa24509-cr-0009" contrib-type="author" corresp="yes"><name name-style="western"><surname>Di Rosa</surname><given-names initials="F">Francesca</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0252-9138</contrib-id><xref rid="cytoa24509-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>francesca.dirosa@cnr.it</email></address></contrib></contrib-group><aff id="cytoa24509-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Institute of Molecular Biology and Pathology</named-content>
<institution>National Research Council of Italy (CNR)</institution>
<city>Rome</city>
<country country="IT">Italy</country>
</aff><aff id="cytoa24509-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Molecular Medicine</named-content>
<institution>University of Rome &#8220;Sapienza&#8221;</institution>
<city>Rome</city>
<country country="IT">Italy</country>
</aff><aff id="cytoa24509-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Center for Life Nano&#8208; &amp; Neuro&#8208;Science</named-content>
<institution>Fondazione Istituto Italiano di Tecnologia (IIT)</institution>
<city>Rome</city>
<country country="IT">Italy</country>
</aff><aff id="cytoa24509-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Immunosurveillance Laboratory</named-content>
<institution>The Francis Crick Institute</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><aff id="cytoa24509-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Peter Gorer Department of Immunobiology</named-content>
<institution>King's College London</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><aff id="cytoa24509-aff-0006">
<label>
<sup>6</sup>
</label>
<institution>National Institute for Health Research (NIHR) Biomedical Research Center (BRC), Guy's and St Thomas' NHS Foundation Trust and King's College London</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><aff id="cytoa24509-curr-0001"><label>
<sup>7</sup>
</label>Present address:
<institution>Medical Oncology Department, Campus Bio&#8208;Medico University</institution>
<city>Rome</city>
<country country="IT">Italy</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Ambra Natalini, Institute of Molecular Biology and Pathology, National Research Council of Italy (CNR), Viale Regina Elena 291, Rome 00161, Italy.<break/>
Email: <email>ambra.natalini@ibpm.cnr.it</email><break/>
Francesca Di Rosa, Institute of Molecular Biology and Pathology, National Research Council of Italy (CNR), Viale Regina Elena 291, Rome 00161, Italy.<break/>
Email: <email>francesca.dirosa@cnr.it</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>10</month><year>2021</year></pub-date><pub-date pub-type="ppub"><month>12</month><year>2021</year></pub-date><volume>99</volume><issue seq="80">12</issue><issue-id pub-id-type="pmc-issue-id">418734</issue-id><issue-id pub-id-type="doi">10.1002/cyto.a.v99.12</issue-id><issue-title content-type="special-issue-title">Cellular Astronomy in Honor of Howard Shapiro</issue-title><fpage>1171</fpage><lpage>1175</lpage><history><date date-type="rev-recd"><day>13</day><month>9</month><year>2021</year></date><date date-type="received"><day>08</day><month>1</month><year>2021</year></date><date date-type="accepted"><day>30</day><month>9</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>07</day><month>10</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>14</day><month>10</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2022-10-15 00:17:55.123"><day>15</day><month>10</month><year>2022</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2021 The Authors. <italic toggle="yes">Cytometry Part A</italic> published by Wiley Periodicals LLC. on behalf of International Society for Advancement of Cytometry.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CYTO-99-1171.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CYTO-99-1171.pdf"/><abstract><title>Abstract</title><p>A multicolor flow cytometry panel was designed and optimized to define the following nine mouse T cell subsets: Treg (CD3<sup>+</sup> CD4<sup>+</sup> CD8<sup>&#8722;</sup> FoxP3<sup>+</sup>), CD4<sup>+</sup> T na&#239;ve (CD3<sup>+</sup> CD4<sup>+</sup> CD8<sup>&#8722;</sup>FoxP3<sup>&#8722;</sup> CD44<sup>int/low</sup> CD62L<sup>+</sup>), CD4<sup>+</sup> T central memory (CD3<sup>+</sup> CD4<sup>+</sup> CD8<sup>&#8722;</sup> FoxP3<sup>&#8722;</sup> CD44<sup>high</sup> CD62L<sup>+</sup>), CD4<sup>+</sup> T effector memory (CD3<sup>+</sup> CD4<sup>+</sup> CD8<sup>&#8722;</sup> FoxP3<sup>&#8722;</sup> CD44<sup>high</sup> CD62L<sup>&#8722;</sup>), CD4<sup>+</sup> T EMRA (CD3<sup>+</sup> CD4<sup>+</sup> CD8<sup>&#8722;</sup> FoxP3<sup>&#8722;</sup> CD44<sup>int/low</sup> CD62L<sup>&#8722;</sup>), CD8<sup>+</sup> T na&#239;ve (CD3<sup>+</sup> CD8<sup>+</sup> CD4<sup>&#8722;</sup> CD44<sup>int/low</sup> CD62L<sup>+</sup>), CD8<sup>+</sup> T central memory (CD3<sup>+</sup> CD8<sup>+</sup> CD4<sup>&#8722;</sup> CD44<sup>high</sup> CD62L<sup>+</sup>), CD8<sup>+</sup> T effector memory (CD3<sup>+</sup> CD8<sup>+</sup> CD4<sup>&#8722;</sup> CD44<sup>high</sup> CD62L<sup>&#8722;</sup>), and CD8<sup>+</sup> T EMRA (CD3<sup>+</sup> CD8<sup>+</sup> CD4<sup>&#8722;</sup> CD44<sup>int/low</sup> CD62L<sup>&#8722;</sup>). In each T cell subset, a dual staining for Ki&#8208;67 expression and DNA content was employed to distinguish the following cell cycle phases: G<sub>0</sub> (Ki67<sup>&#8722;</sup>, with 2n DNA), G<sub>1</sub> (Ki67<sup>+</sup>, with 2n DNA), and S&#8208;G<sub>2</sub>/M (Ki67<sup>+</sup>, with 2n&#8201;&lt;&#8201;DNA&#8201;&#8804;&#8201;4n). This panel was established for the analysis of mouse (C57BL/6J) spleen.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="cytoa24509-kwd-0001">cell cycle</kwd><kwd id="cytoa24509-kwd-0002">DNA content</kwd><kwd id="cytoa24509-kwd-0003">flow cytometry</kwd><kwd id="cytoa24509-kwd-0004">Ki&#8208;67</kwd><kwd id="cytoa24509-kwd-0005">mouse T cells</kwd><kwd id="cytoa24509-kwd-0006">spleen</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Consiglio Nazionale delle Ricerche
</institution><institution-id institution-id-type="doi">10.13039/501100004462</institution-id></institution-wrap></funding-source><award-id>STM&#8208;2019</award-id></award-group><award-group id="funding-0002"><funding-source>Italian Minister of Research and University (MIUR)</funding-source><award-id>2017K55HLC</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="5"/><word-count count="4596"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC-ND</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>December 2021</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.0 mode:remove_FC converted:07.10.2022</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="cytoa24509-cit-9001"><string-name name-style="western"><surname>Natalini</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Simonetti</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Favaretto</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Peruzzi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Antonangeli</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Santoni</surname><given-names>A</given-names></string-name>, et al. <article-title>
<styled-content style="fixed-case" toggle="no">OMIP</styled-content>&#8208;079: Cell cycle of <styled-content style="fixed-case" toggle="no">CD4</styled-content>
<sup>+</sup> and <styled-content style="fixed-case" toggle="no">CD8</styled-content>
<sup>+</sup> na&#239;ve/memory T cell subsets, and of Treg cells from mouse spleen</article-title>. <source>Cytometry</source>. <year>2021</year>;<volume>99</volume>:<fpage>1171</fpage>&#8211;<lpage>1175</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.24509</pub-id><pub-id pub-id-type="pmid">34668313</pub-id><pub-id pub-id-type="pmcid">PMC9543383</pub-id></mixed-citation>
</p><fn-group id="cytoa24509-ntgp-0101"><fn id="cytoa24509-note-0101"><p>[Correction added on 22 October 2021, after first online publication: The last name of the author has been updated from &#8220;Munoz&#8208;Ruiz&#8221; to &#8220;Mu&#241;oz&#8208;Ruiz&#8221;.]</p></fn><fn id="cytoa24509-note-1002"><p>
<bold>Funding information</bold> Consiglio Nazionale delle Ricerche, Grant/Award Number: STM&#8208;2019; Italian Minister of Research and University (MIUR), Grant/Award Number: 2017K55HLC</p></fn></fn-group></notes></front><body id="cytoa24509-body-0001"><sec sec-type="background" id="cytoa24509-sec-0001"><label>1</label><title>BACKGROUND</title><p>The periodicity of cell proliferation is a fundamental aspect of biology that, for example, discriminates neural stem cells from terminally differentiated neurons. Likewise, it is a key feature of adaptive immunity that depends upon clonal expansion of primed T and B cells with appropriate antigen specificity, thereupon generating a vast progeny of short&#8208;lived effector cells and a few long&#8208;lived memory cells. There are two main subsets of T cells, CD4<sup>+</sup> and CD8<sup>+</sup> T cells, having a predominant helper and cytotoxic effector function, respectively. Maintenance of memory CD4<sup>+</sup> and CD8<sup>+</sup> T cells over time is a dynamic process, relying on a fine equilibrium among cell death, survival, and low level of homeostatic proliferation [<xref rid="cytoa24509-bib-0001" ref-type="bibr">1</xref>, <xref rid="cytoa24509-bib-0002" ref-type="bibr">2</xref>]. Under steady&#8208;state conditions, most T cells in the spleen of untreated mice are quiescent cells, although a tiny proportion divides, possibly reflecting immune responses to unknown environmental antigens and/or cytokine&#8208;driven homeostatic proliferation. Such cell cycling in the absence of intentional immunization is more prominent among the so&#8208;called memory&#8208;phenotype T cells, that share a set of membrane markers with antigen&#8208;primed T cells [<xref rid="cytoa24509-bib-0003" ref-type="bibr">3</xref>]. Furthermore, some Treg cells (a subset of CD4<sup>+</sup> T cells with regulatory function defined by the expression of the transcription factor FoxP3 [<xref rid="cytoa24509-bib-0004" ref-type="bibr">4</xref>]) have an activated/proliferative phenotype, possibly reflecting continuous self&#8208;renewal in adult mice [<xref rid="cytoa24509-bib-0005" ref-type="bibr">5</xref>].</p><p>In fact, memory&#8208;phenotype T cells comprise a heterogeneous pool of cells of undefined antigen&#8208;specificity, that are considered to include T cells primed by environmental antigens, as well as some antigen&#8208;inexperienced T cells having self&#8208;ligand&#8208; and/or cytokine&#8208;dependent development [<xref rid="cytoa24509-bib-0006" ref-type="bibr">6</xref>, <xref rid="cytoa24509-bib-0007" ref-type="bibr">7</xref>]. In C57BL/6 mice memory&#8208;phenotype T cells have a high expression of CD44, an adhesion molecule that binds to hyaluronic acid, and can thus be distinguished from na&#239;ve&#8208;phenotype T cells, that have an intermediate/low CD44 expression [<xref rid="cytoa24509-bib-0006" ref-type="bibr">6</xref>]. Similarly, in humans na&#239;ve and memory&#8208;phenotype T cells can be identified by high and low expression of CD45RA, respectively [<xref rid="cytoa24509-bib-0008" ref-type="bibr">8</xref>].</p><p>Proliferative potential is one of the features that, together with lymph node (LN) homing capabilities, and effector function, differentiates additional subsets among memory T cells. Thus, central memory (CM) T cells have a LN homing receptor typically expressed by na&#239;ve T cells, specifically CD62L, also named L&#8208;selectin, a glycan receptor [<xref rid="cytoa24509-bib-0009" ref-type="bibr">9</xref>], whereas effector memory (EM) T cells lack it [<xref rid="cytoa24509-bib-0010" ref-type="bibr">10</xref>]. According to this classification, originally proposed for human blood T cells using CCR7, the chemokine receptor for CCL19/CCL21, as a marker [<xref rid="cytoa24509-bib-0011" ref-type="bibr">11</xref>], T CM are LN&#8208;homing cells with high potential to expand after stimulation, while T EM cells are tissue&#8208;homing cells able to display rapid effector function [<xref rid="cytoa24509-bib-0012" ref-type="bibr">12</xref>, <xref rid="cytoa24509-bib-0013" ref-type="bibr">13</xref>]. An additional subset, the T EMRA cells, comprises effector memory T cells that re&#8208;acquire a na&#239;ve phenotype (CD45RA<sup>+</sup> in humans, CD44<sup>int/low</sup> in mice). Based on this, the following four na&#239;ve/memory T cell subsets can be identified among mouse CD4<sup>+</sup> and CD8<sup>+</sup> T cells: CD44<sup>int/low</sup> CD62L<sup>+</sup> na&#239;ve, CD44<sup>high</sup> CD62L<sup>+</sup> CM, CD44<sup>high</sup> CD62L<sup>&#8722;</sup> EM, and CD44<sup>int/low</sup> CD62L<sup>&#8722;</sup> EMRA [<xref rid="cytoa24509-bib-0010" ref-type="bibr">10</xref>, <xref rid="cytoa24509-bib-0014" ref-type="bibr">14</xref>].</p><p>While identification of memory T cells with high proliferative potential can impact the success of adoptive transfers [<xref rid="cytoa24509-bib-0015" ref-type="bibr">15</xref>], accurate measurement of in vivo proliferation is essential to track the dynamics of T cell responses [<xref rid="cytoa24509-bib-0016" ref-type="bibr">16</xref>]. Proliferation of mouse T cells has been measured by a few cytofluorimetric methods, that can be divided into &#8220;static&#8221;&#8212;that is, those which provide a snapshot of the cell cycle phases at the time of analysis&#8212;and &#8220;dynamic,&#8221; that is, those which give information on the proliferation that occurred over a few hours or days prior to the analysis. The most widely used &#8220;static&#8221; method relies on the Ki&#8208;67 marker, an intranuclear protein that supports chromosome architecture organization, and nucleus and nucleolar assembly after cell division [<xref rid="cytoa24509-bib-0017" ref-type="bibr">17</xref>, <xref rid="cytoa24509-bib-0018" ref-type="bibr">18</xref>]. However, Ki&#8208;67 is expressed by cells in any phase of cell cycle (i.e., in G<sub>1</sub>, S, G<sub>2</sub>, M), while it is only low or absent in quiescent cells (i.e., in G<sub>0</sub> state). The &#8220;dynamic&#8221; methods include carboxyfluorescein succinimidyl ester (CFSE) and Bromodeoxyuridine (BrdU) labelling, which identify proliferating cells that have undergone cell division and S&#8208;phase, respectively [<xref rid="cytoa24509-bib-0002" ref-type="bibr">2</xref>]. We chose to combine Ki&#8208;67 staining and DNA content analysis, thereby to distinguish between cells in G<sub>1</sub> and those in S&#8208;G<sub>2</sub>/M phases of cell cycle, a discrimination that is relevant to the proliferative fate of the cell. Indeed, cells in S are duplicating their DNA and are committed to proceed into G<sub>2</sub>/M and divide. In contrast, cells that are in G<sub>1</sub> might proceed into S&#8208;G<sub>2</sub>/M, return to G<sub>0</sub>, or stay in G<sub>1</sub> for a prolonged period. Thus, Ki&#8208;67<sup>+</sup> cells might not be actively proliferating if they are in G<sub>1</sub> phase or are returning to G<sub>0</sub>. For example, this might be the case for antigen&#8208;specific T cell progeny at the end of clonal expansion [<xref rid="cytoa24509-bib-0019" ref-type="bibr">19</xref>].</p><p>In this OMIP, we offer a staining panel for ex vivo cell cycle analysis of CD4<sup>+</sup> and CD8<sup>+</sup> na&#239;ve/memory&#8208;phenotype T cell subsets, and of Treg cells from mouse spleen, using Ki&#8208;67/DNA dual staining to distinguish cells in G<sub>0</sub>, G<sub>1</sub>, and S&#8208;G<sub>2</sub>/M (Table&#160;<xref rid="cytoa24509-tbl-0001" ref-type="table">1</xref>; Figure&#160;<xref rid="cytoa24509-fig-0001" ref-type="fig">1</xref>). Panel optimization and protocol details are reported in the online <xref rid="cytoa24509-supitem-0002" ref-type="supplementary-material">Supporting Information</xref>. We used standard markers for T cell subset identification. CD3 expression was used to identify T cells, and the mutually exclusive expression of CD4 and CD8 to distinguish CD4<sup>+</sup> and CD8<sup>+</sup> T cells, respectively. Treg cells were identified among CD4<sup>+</sup> T cells based on their expression of the intranuclear protein FoxP3, and by this marker distinguished from conventional CD4<sup>+</sup> T cells, that is, FoxP3<sup>&#8722;</sup> CD3<sup>+</sup> CD4<sup>+</sup> CD8<sup>&#8722;</sup> cells. CD4<sup>+</sup> and CD8<sup>+</sup> na&#239;ve/memory T cell subsets were subsequently identified among conventional CD4<sup>+</sup> and CD8<sup>+</sup> T cells, respectively. The four classical na&#239;ve/memory subsets were defined based on their CD62L and CD44 membrane phenotype (see above). For each T cell subset, cells in G<sub>0</sub>, G<sub>1</sub>, and S&#8208;G<sub>2</sub>/M were discriminated based on Ki&#8208;67 and DNA staining (Table&#160;<xref rid="cytoa24509-tbl-0002" ref-type="table">2</xref>; Figure&#160;<xref rid="cytoa24509-fig-0001" ref-type="fig">1</xref>).</p><table-wrap position="float" id="cytoa24509-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Summary table for the application of OMIP&#8208;079</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Purpose</td><td align="left" valign="top" rowspan="1" colspan="1">Cell cycle analysis of CD4 and CD8 na&#239;ve/memory T cell subsets, and of Treg cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Species</td><td align="left" valign="top" rowspan="1" colspan="1">Mouse</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell types</td><td align="left" valign="top" rowspan="1" colspan="1">Splenocytes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cross&#8208;references</td><td align="left" valign="top" rowspan="1" colspan="1">No similar OMIPs</td></tr></tbody></table></table-wrap><fig position="float" fig-type="FIGURE" id="cytoa24509-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Cell cycle analysis of mouse T cell subsets. Example of analysis of spleen cells from a 3&#8208;months old C57BL/6J mouse, using manual gating strategy. (A) Refined gating of viable single cells from the spleen in five steps: (1) DNA singlets. Single cells having 2n&#8201;&#8804;&#8201;DNA content &#8804;4n were selected on the Hoechst&#8208;33342 area (A) versus (vs) Hoechst&#8208;33342 width (W) plot; (2) time exclusion. Stable acquisition over time (seconds) was monitored on the time vs Hoechst&#8208;33342&#8208;A plot and any events collected in case of pressure fluctuations were excluded; (3) viable cells. Live cells were selected using FSC&#8208;A vs eFluor 780 (eF780) viability dye; (4) FSC/SSC &#8220;relaxed&#8221; gate. A &#8220;relaxed&#8221; gate was used on the FSC&#8208;A vs SSC&#8208;A plot, to include highly activated and cycling lymphocytes [<xref rid="cytoa24509-bib-0019" ref-type="bibr">19</xref>]; (5) refined singlets. A few remaining doublets composed by one cell sitting on top of another (so called &#8220;shadow&#8221; doublets) were excluded as Ki&#8208;67<sup>int</sup>/<sup>&#8722;</sup> events having &gt;2n DNA content [<xref rid="cytoa24509-bib-0020" ref-type="bibr">20</xref>]. This gating strategy was used as a base for the subsequent gates. (B) CD3<sup>+</sup> T cells were gated on CD3&#8208;A vs Ki&#8208;67&#8208;A plot, then CD4<sup>+</sup> and CD8<sup>+</sup> T cells on CD4&#8208;A vs CD8&#8208;A plot. CD4<sup>+</sup> Treg cells were distinguished based on their FoxP3 expression from conventional FoxP3<sup>&#8722;</sup> CD4<sup>+</sup> T cells. Subsequently, the following na&#239;ve/memory subsets of conventional CD4<sup>+</sup> T cells were identified: CD44<sup>int/low</sup>CD62L<sup>+</sup> na&#239;ve, CD44<sup>high</sup>CD62L<sup>+</sup> central memory (CM), CD44<sup>high</sup>CD62L<sup>&#8722;</sup> effector memory (EM), and CD44<sup>int/low</sup>CD62L<sup>&#8722;</sup> EMRA. Similarly, na&#239;ve/memory subsets were identified among CD8<sup>+</sup> T cells. (C) Cell cycle phases of Treg cells and of na&#239;ve/memory CD4<sup>+</sup> and CD8<sup>+</sup> T cell subsets were defined on Hoechst&#8208;33342&#8208;A vs Ki67&#8208;A plot as follows: Cells in G<sub>0</sub> were identified as DNA 2n/ Ki67<sup>&#8722;</sup> (bottom left quadrant); cells in G<sub>1</sub> as DNA 2n/ Ki67<sup>+</sup> (upper left quadrant); cells in S&#8208;G<sub>2</sub>/M as DNA&#8201;&gt;&#8201;2n/ Ki67<sup>+</sup> (top right quadrant) [Color figure can be viewed at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://wileyonlinelibrary.com" ext-link-type="uri">wileyonlinelibrary.com</ext-link>]</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="CYTO-99-1171-g001.jpg"/></fig><table-wrap position="float" id="cytoa24509-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Reagents used for OMIP&#8208;079</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Fluorochrome</th><th align="left" valign="bottom" rowspan="1" colspan="1">Specificity</th><th align="left" valign="bottom" rowspan="1" colspan="1">Clone</th><th align="left" valign="bottom" rowspan="1" colspan="1">Function</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">CD3</td><td align="left" valign="top" rowspan="1" colspan="1">145&#8208;2C11</td><td align="left" valign="top" rowspan="1" colspan="1">Pan T cell marker</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APC</td><td align="left" valign="top" rowspan="1" colspan="1">CD44</td><td align="left" valign="top" rowspan="1" colspan="1">IM7</td><td align="left" valign="top" rowspan="1" colspan="1">Na&#207;ve/Memory subset identification</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alexa Fluor 700</td><td align="left" valign="top" rowspan="1" colspan="1">Ki&#8208;67</td><td align="left" valign="top" rowspan="1" colspan="1">SolA15</td><td align="left" valign="top" rowspan="1" colspan="1">Quiescence/cell cycle</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">eFluor 780</td><td align="left" valign="top" rowspan="1" colspan="1">Dead cells</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">Live/Dead cell discrimination</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hoechst 33342</td><td align="left" valign="top" rowspan="1" colspan="1">DNA</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">DNA content/cell cycle</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PE</td><td align="left" valign="top" rowspan="1" colspan="1">FoxP3</td><td align="left" valign="top" rowspan="1" colspan="1">FJK&#8208;16s</td><td align="left" valign="top" rowspan="1" colspan="1">Treg identification</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;CF594</td><td align="left" valign="top" rowspan="1" colspan="1">CD4</td><td align="left" valign="top" rowspan="1" colspan="1">RM4&#8208;5</td><td align="left" valign="top" rowspan="1" colspan="1">Helper T cell identification</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;Cy7</td><td align="left" valign="top" rowspan="1" colspan="1">CD62L</td><td align="left" valign="top" rowspan="1" colspan="1">MEL&#8208;14</td><td align="left" valign="top" rowspan="1" colspan="1">Na&#207;ve/Memory subset identification</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BV785</td><td align="left" valign="top" rowspan="1" colspan="1">CD8</td><td align="left" valign="top" rowspan="1" colspan="1">53&#8208;6.7</td><td align="left" valign="top" rowspan="1" colspan="1">Cytotoxic T cell identification</td></tr></tbody></table><table-wrap-foot id="cytoa24509-ntgp-0002"><fn id="cytoa24509-note-0001"><p>Abbreviation: N/A, not applicable.</p></fn></table-wrap-foot></table-wrap><p>This OMIP can be exploited for in depth&#8208;analysis of T cell cycle in conditions characterized by altered proportions, numbers and proliferative state of spleen T cell subsets, for example in aged mice having higher percentages of memory CD4<sup>+</sup> and CD8<sup>+</sup> T cells, with or without oligoclonal expansion [<xref rid="cytoa24509-bib-0021" ref-type="bibr">21</xref>, <xref rid="cytoa24509-bib-0022" ref-type="bibr">22</xref>, <xref rid="cytoa24509-bib-0023" ref-type="bibr">23</xref>]; in lymphopenic mice having compensatory T cell proliferation [<xref rid="cytoa24509-bib-0024" ref-type="bibr">24</xref>]; or in genetically modified mice with abnormal Treg cells representation [<xref rid="cytoa24509-bib-0025" ref-type="bibr">25</xref>]. Furthermore, this panel may be instrumental in identifying hitherto overlooked changes in Treg and/or na&#239;ve/memory T cell subset cycling in a variety of settings such as vaccination, infection, autoimmunity, and cancer.</p></sec><sec id="cytoa24509-sec-0002"><label>2</label><title>SIMILARITY TO PUBLISHED <styled-content style="fixed-case" toggle="no">OMIPS</styled-content>
</title><p>The new ground trodden by this OMIP is the examination of cell cycle of na&#239;ve/memory CD4<sup>+</sup> and CD8<sup>+</sup> T cell subsets and of Treg cells by Ki&#8208;67/DNA dual staining, with no similarities to other OMIPs.</p><p>OMIP&#8208;031 and &#8208;032 examined na&#239;ve/memory T cells, with different purposes. OMIP&#8208;031 used a combination of CD44, CD62L, CD27, CD45RA for T cell subset definition, plus a panel of activation and exhaustion markers, with the aim to analyze inhibitor checkpoint expression. OMIP&#8208;032 was designed for assessing innate and adaptive immune subsets from mouse organs, including na&#239;ve/memory T cell subsets, that were identified based on CD44 and CD62L expression. OMIP&#8208;032 did not include any analysis of proliferation or cell cycle.</p></sec><sec sec-type="COI-statement" id="cytoa24509-sec-0004"><title>CONFLICT OF INTEREST</title><p>A.C.H. is a board member and equity holder in ImmunoQure, AG., and Gamma Delta Therapeutics, and is an equity holder in Adaptate Biotherapeutics.</p></sec><sec id="cytoa24509-sec-0005"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Ambra Natalini:</bold> Conceptualization (lead); data curation (lead); formal analysis (lead); investigation (lead); methodology (lead); writing &#8211; review and editing (supporting). <bold>Sonia Simonetti:</bold> Conceptualization (supporting); formal analysis (supporting); investigation (supporting); methodology (supporting); writing &#8211; review and editing (supporting). <bold>Gabriele Favaretto:</bold> Data curation (supporting); formal analysis (supporting); methodology (supporting); writing &#8211; review and editing (supporting). <bold>Giovanna Peruzzi:</bold> Data curation (supporting); formal analysis (supporting); writing &#8211; review and editing (supporting). <bold>Fabrizio Antonangeli:</bold> Data curation (supporting); formal analysis (supporting); writing &#8211; review and editing (supporting). <bold>Angela Santoni:</bold> Writing &#8211; review and editing (supporting). <bold>Miguel Munoz&#8208;Ruiz:</bold> Methodology (supporting); writing &#8211; review and editing (supporting). <bold>Adrian Hayday:</bold> Supervision (supporting); writing &#8211; review and editing (supporting). <bold>Francesca Di Rosa:</bold> Conceptualization (lead); supervision (lead); writing &#8211; original draft (lead).</p></sec><sec id="cytoa24509-sec-0006"><sec disp-level="2" id="cytoa24509-sec-0007"><title>PEER REVIEW</title><p>The peer review history for this article is available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://publons.com/publon/10.1002/cyto.a.24509" ext-link-type="uri">https://publons.com/publon/10.1002/cyto.a.24509</ext-link>.</p></sec></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="cytoa24509-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Appendix</bold>
<bold>S1</bold>. <bold>MIFlowCyt</bold> MIFlowCyt Item Checklist: MIFlowCyt&#8208;Compliant Items.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s005.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Appendix</bold>
<bold>S2</bold>. Supporting Information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s011.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0003" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S1</bold> Spillover spreading error (SSE) matrix (SSM). SSM was obtained with compensation beads, except for eF780 viability dye and Hoechst&#8208;33342, which were compensated using live and dead splenocytes (1:1 mix) and bone marrow cells, respectively. SSE values &gt;10 are highlighted in orange.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s013.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0004" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S2</bold> Titration of the DNA dye Hoechst&#8208;33342 (Hoechst) and of the fixable viability dye eFluor 780 (eF780). (A) Hoechst titration with four 2&#8208;fold dilutions. Titration was performed in parallel using either spleen (top) or bone marrow (BM) cells (bottom). Histogram plots show Hoechst fluorescence intensity on the x&#8208;axis, using a linear scale in arbitrary units. The left and right gates correspond to the G<sub>0</sub>/G<sub>1</sub> and the G<sub>2</sub>/M DNA peak, respectively, and the numbers represent the coefficients of variation (CV) of each peak. (B) Spreading of signal of Hoechst at 2 and 4&#160;&#956;g/ml in the indicated channels. All the channels were set identically at the two concentrations, except for UV laser (bandpass 530/30), i.e., the Hoechst channel, that was adapted for visualization of the DNA peaks by changing PMT voltage (decreasing PMT voltage for increasing Hoechst concentration). Histograms show fluorescence intensity in arbitrary units of unstained spleen cells (dotted empty line) and spleen cells stained with Hoechst (gray filled line) at either 2 or 4&#160;&#956;g/ml, as indicated. Laser (color code) and bandpass are indicated on top of each channel. Laser color code as follows: blue for 488&#8201;nm (blue) laser; red for 639&#8201;nm (red) laser; green for 561&#8201;nm (yellow/green) laser; black for 355&#8201;nm (UV) laser; violet for 405&#8201;nm (violet) laser. Where appropriate, fluorochromes used in this OMIP are indicated, although only Hoechst was used here. Hoechst concentration at 2&#160;&#956;g/ml (in red) was chosen as it resulted in DNA peaks having CV&#8201;&#8804;&#8201;5 (A), and lower signal spreading than Hoechst at 4&#160;&#956;g/ml (B). (C) Viability dye eF780 titration with five 2&#8208;fold dilutions. The titer is shown on the x&#8208;axis as dilution factor of the reagent, and the fluorescence intensity on the y&#8208;axis, in arbitrary units (corresponding laser is indicated, with bandpass in parentheses). Files were concatenated for analysis using FlowJo version 10.7.1 (BD software). (D) eF780 Stain Index (SI) and percentage of positive cells. The eF780 titer is shown on the x&#8208;axis as dilution factor, and SI and percentage of positive cells are represented on the left and right y&#8208;axis, respectively. The titer with maximal or near maximal percentage of positive cells and high SI was chosen. The chosen titer (1:500) is highlighted with a red frame (C) and a red font (D).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s015.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0005" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S3</bold> Antibody titration on spleen cells stained with eF780 and Hoechst. Eight 2&#8208;fold dilutions were tested for each antibody. Titration of CD4 PE&#8208;CF594, CD8 BV785, CD62L PE&#8208;Cy7, and Ki&#8208;67 AF700 was performed on CD3 FITC co&#8208;stained cells. Titration of CD44 APC, and FoxP3 PE was performed on CD3 FITC and CD4 PE&#8208;CF594 co&#8208;stained cells. The concentration is shown on the x&#8208;axis in &#956;g/ml (final concentration, in a total staining volume of 100&#8201;&#956;l for FoxP3 and Ki&#8208;67 mAb, and 50&#8201;&#956;l for all the other mAbs). For each antibody titration, concatenated files were represented (top), and SI and percentage of positive cells plotted (bottom), as in Online Figure 2C and D. The concentration with maximal or near maximal percentage of positive cells and high SI was chosen. The chosen titer is highlighted with a red frame (top) and a red font (bottom).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s007.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0006" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S4</bold> Antibody titration on spleen cells stained with eF780. Titration was performed following the same scheme as in Online Figure 3, but without Hoechst.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s010.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0007" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S5</bold> Fluorescence Minus One (FMOs). FMOs were used as quality controls for assessment of the accuracy of gates used to identify cell populations in Figure 1B and C. The following FMO plots are represented: (A) Ki&#8208;67; (B) CD3; (C) CD4; (D) CD8; (E) FoxP3; (F) CD44; (G) CD62L. Please, note that the CD44<sup>int/low</sup> and CD44<sup>high</sup> populations were defined based on the level of expression of CD44, rather than on the FMO control.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s002.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0008" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S6</bold> eF780 staining control. Freshly obtained spleen cells were stained with eF780, then either incubated with surface mAbs as in Figure 1 or not (gray filled circles). In parallel, spleen cells were either incubated with surface mAbs as in Figure 1 or not, then stained with eF780 (black filled triangles). All samples were then fixed and permeabilized according to our protocol. Surface mAb stained samples were stained with intracellular mAbs as in Figure 1 (Full stained), while the remaining samples were not (no mAbs). Finally, all samples were incubated with Hoechst. The percentage of viable cells was determined using the gating strategy shown in Figure 1. The panel summarizes the results of 4 independent experiments. Mean values and Standard Deviations are represented. Statistical analysis was performed using Friedman test with Dunn's multiple comparison (*<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s003.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0009" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S7</bold> Antibody titration on spleen cells stained with eF780 and Hoechst. Six or eight 2&#8208;fold dilutions were tested for each antibody. Titration of CD4 PerCp&#8208;Cy5.5, CD4 BUV737, CD8 BUV805, CD8 PE&#8208;Cy5 and CD8 PE&#8208;Cy7 was performed on CD3 FITC co&#8208;stained cells. The concentration is shown on the x&#8208;axis in &#956;g/ml (final concentration, in a total staining volume of 50&#8201;&#956;l). For each antibody titration, concatenated files were represented (top), and SI and percentage of positive cells plotted (bottom), as in Online Figure 3. The concentration with maximal or near maximal percentage of positive cells and high SI was chosen. The chosen titer is highlighted with a red frame (top) and a red font (bottom). The mAbs in this figure were not included in the final panel (reason for exclusion in Online Table 3).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s009.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0010" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S8</bold> Alternative options for Ki67 and FoxP3 mAbs. Freshly obtained spleen cells were stained using either mAbs and reagents of this OMIP panel (A) or a modified panel to test the following mAbs (indicated in red): (B) Ki&#8208;67 PE and FoxP3 AF700; (C) Ki&#8208;67 APC, FoxP3 AF700 and CD44 PE; (D) Ki&#8208;67 PE&#8208;Cy7, FoxP3 AF700, CD44 PE and CD62L APC. Each of these mAbs replaced the corresponding marker&#8208;specific mAb in this OMIP panel. Data were analyzed using the gating strategy shown in Figure 1, and representative plots are shown, as indicated. The mAbs in this figure were not included in the final panel (reasons for exclusion in Online Table 3).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s004.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0011" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S9</bold> Alternative options for CD44 and CD62L mAbs. Freshly obtained spleen cells were stained using either mAbs and reagents of this OMIP panel (A&#8208;C), or CD44 PE&#8208;Cy7 and CD62L APC (in red) replacing the corresponding marker&#8208;specific mAbs in this OMIP panel (D&#8208;F). Data were analyzed using the gating strategy shown in Figure 1, and representative plots are shown, as indicated. Fully stained samples are shown in A and D; CD44 FMO controls in B and E; CD62L FMO controls in C and F. Please, note that the CD44<sup>int/low</sup> and CD44<sup>high</sup> populations were defined based on the level of expression of CD44, rather than on the FMO control. CD44 PE&#8208;Cy7 and CD62L APC mAbs were not included in the final panel (reasons for exclusion in Online Table 3).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s012.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0012" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S10</bold> Scheme of gating strategy.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s016.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0013" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Figure S11</bold> Cell cycle analysis of spleen T cell subsets from a 6&#8208;months old C57BL/6J mouse. Example of staining and gating of spleen cells from a 6&#8208;months old C57BL/6J mouse, using the same gating strategy as in Figure 1.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s008.tif" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0014" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S1</bold> Instrument configuration of the cytometer BD LSR Fortessa.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s001.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0015" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S2</bold> Commercially available reagents used in OMIP&#8208;079.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s006.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="cytoa24509-supitem-0016" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S3</bold> Antibodies tested but not used for the final panel (all tested with Hoechst).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-99-1171-s014.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="cytoa24509-sec-0003"><title>ACKNOWLEDGMENTS</title><p>The authors wish to thank Hefin Rhys (Flow Cytometry Science Technology Platform, The Francis Crick Institute, London UK) for discussion, and Antonio Di Virgilio (Istituto Superiore di Sanit&#224;, Rome, Italy) for technical help in the mouse facility. Open Access Funding provided by Consiglio Nazionale delle Ricerche within the CRUI&#8208;CARE Agreement.</p></ack><ref-list id="cytoa24509-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="cytoa24509-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0001"><string-name name-style="western"><surname>Farber</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Netea</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Radbruch</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rajewsky</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Zinkernagel</surname><given-names>RM</given-names></string-name>. <article-title>Immunological memory: lessons from the past and a look to the future</article-title>. <source>Nat Rev Immunol</source>. <year>2016</year>;<volume>16</volume>:<fpage>124</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">26831526</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri.2016.13</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0002"><string-name name-style="western"><surname>Di Rosa</surname><given-names>F</given-names></string-name>. <article-title>Two niches in the bone marrow: a hypothesis on life&#8208;long T cell memory</article-title>. <source>Trends Immunol</source>. <year>2016</year>;<volume>37</volume>:<fpage>503</fpage>&#8211;<lpage>12</lpage>.<pub-id pub-id-type="pmid">27395354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2016.05.004</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0003"><string-name name-style="western"><surname>Tough</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Sprent</surname><given-names>J</given-names></string-name>. <article-title>Turnover of naive&#8208; and memory&#8208;phenotype T cells</article-title>. <source>J Exp Med</source>. <year>1994</year>;<volume>179</volume>:<fpage>1127</fpage>&#8211;<lpage>35</lpage>.<pub-id pub-id-type="pmid">8145034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.179.4.1127</pub-id><pub-id pub-id-type="pmcid">PMC2191431</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0004"><string-name name-style="western"><surname>Lahl</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Loddenkemper</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Drouin</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Freyer</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Arnason</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Eberl</surname><given-names>G</given-names></string-name>, et al. <article-title>Selective depletion of Foxp3+ regulatory T cells induces a scurfy&#8208;like disease</article-title>. <source>J Exp Med</source>. <year>2007</year>;<volume>204</volume>:<fpage>57</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="pmid">17200412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20061852</pub-id><pub-id pub-id-type="pmcid">PMC2118432</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0005"><string-name name-style="western"><surname>Rubtsov</surname><given-names>YP</given-names></string-name>, <string-name name-style="western"><surname>Niec</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Josefowicz</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Darce</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mathis</surname><given-names>D</given-names></string-name>, et al. <article-title>Stability of the regulatory T cell lineage in vivo</article-title>. <source>Science</source>. <year>2010</year>;<volume>329</volume>:<fpage>1667</fpage>&#8211;<lpage>71</lpage>.<pub-id pub-id-type="pmid">20929851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1191996</pub-id><pub-id pub-id-type="pmcid">PMC4262151</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0006"><string-name name-style="western"><surname>Sprent</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Surh</surname><given-names>CD</given-names></string-name>. <article-title>Normal T cell homeostasis: the conversion of naive cells into memory&#8208;phenotype cells</article-title>. <source>Nat Immunol</source>. <year>2011</year>;<volume>131</volume>:<fpage>478</fpage>&#8211;<lpage>84</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.2018</pub-id><pub-id pub-id-type="pmcid">PMC3434123</pub-id><pub-id pub-id-type="pmid">21739670</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0007"><string-name name-style="western"><surname>White</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Cross</surname><given-names>EW</given-names></string-name>, <string-name name-style="western"><surname>Kedl</surname><given-names>RM</given-names></string-name>. <article-title>Antigen&#8208;inexperienced memory CD8+ T cells: where they come from and why we need them</article-title>. <source>Nat Rev Immunol</source>. <year>2017</year>;<volume>17</volume>:<fpage>391</fpage>&#8211;<lpage>400</lpage>.<pub-id pub-id-type="pmid">28480897</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri.2017.34</pub-id><pub-id pub-id-type="pmcid">PMC5569888</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0008"><string-name name-style="western"><surname>Beverley</surname><given-names>PC</given-names></string-name>. <article-title>Functional analysis of human T cell subsets defined by CD45 isoform expression</article-title>. <source>Semin Immunol</source>. <year>1992</year>;<volume>4</volume>:<fpage>35</fpage>&#8211;<lpage>41</lpage>.<pub-id pub-id-type="pmid">1534262</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0009"><string-name name-style="western"><surname>Ivetic</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hoskins Green</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Hart</surname><given-names>SJ</given-names></string-name>. <article-title>L&#8208;selectin: a major regulator of leukocyte adhesion, migration and signaling</article-title>. <source>Front Immunol</source>. <year>2019</year>;<volume>10</volume>:<fpage>1068</fpage>.<pub-id pub-id-type="pmid">31139190</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2019.01068</pub-id><pub-id pub-id-type="pmcid">PMC6527602</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0010"><string-name name-style="western"><surname>Del Zotto</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Principi</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Antonini</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Baratto</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Panicucci</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bruno</surname><given-names>C</given-names></string-name>, et al. <article-title>Comprehensive phenotyping of peripheral blood T lymphocytes in healthy mice</article-title>. <source>Cytometry A</source>. <year>2020</year>;<volume>99</volume>(<issue>3</issue>):<fpage>243</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="pmid">33098601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.24246</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0011"><string-name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Lenig</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Forster</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lipp</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></string-name>. <article-title>Two subsets of memory T lymphocytes with distinct homing potentials and effector functions</article-title>. <source>Nature</source>. <year>1999</year>;<volume>401</volume>:<fpage>708</fpage>&#8211;<lpage>12</lpage>.<pub-id pub-id-type="pmid">10537110</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/44385</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0012"><string-name name-style="western"><surname>Weninger</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Crowley</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Manjunath</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>von Andrian</surname><given-names>UH</given-names></string-name>. <article-title>Migratory properties of naive, effector, and memory CD8(+) T cells</article-title>. <source>J Exp Med</source>. <year>2001</year>;<volume>194</volume>:<fpage>953</fpage>&#8211;<lpage>66</lpage>.<pub-id pub-id-type="pmid">11581317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.194.7.953</pub-id><pub-id pub-id-type="pmcid">PMC2193483</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0013"><string-name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Geginat</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></string-name>. <article-title>Central memory and effector memory T cell subsets: function, generation, and maintenance</article-title>. <source>Annu Rev Immunol</source>. <year>2004</year>;<volume>22</volume>:<fpage>745</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="pmid">15032595</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.immunol.22.012703.104702</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0014"><string-name name-style="western"><surname>Unsworth</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Haynes</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Britt</surname><given-names>K</given-names></string-name>. <article-title>OMIP&#8208;032: two multi&#8208;color immunophenotyping panels for assessing the innate and adaptive immune cells in the mouse mammary gland</article-title>. <source>Cytometry A</source>. <year>2016</year>;<volume>89</volume>:<fpage>527</fpage>&#8211;<lpage>30</lpage>.<pub-id pub-id-type="pmid">27214375</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22867</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0015"><string-name name-style="western"><surname>Harris</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Watt</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Ronchese</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Le Gros</surname><given-names>G</given-names></string-name>. <article-title>Differential T cell function and fate in lymph node and nonlymphoid tissues</article-title>. <source>J Exp Med</source>. <year>2002</year>;<volume>195</volume>:<fpage>317</fpage>&#8211;<lpage>26</lpage>.<pub-id pub-id-type="pmid">11828006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20011558</pub-id><pub-id pub-id-type="pmcid">PMC2193599</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0016"><string-name name-style="western"><surname>Borghans</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>de Boer</surname><given-names>RJ</given-names></string-name>. <article-title>Quantification of T&#8208;cell dynamics: from telomeres to DNA labeling</article-title>. <source>Immunol Rev</source>. <year>2007</year>;<volume>216</volume>:<fpage>35</fpage>&#8211;<lpage>47</lpage>.<pub-id pub-id-type="pmid">17367333</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-065X.2007.00497.x</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0017"><string-name name-style="western"><surname>Takagi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Natsume</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kanemaki</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Imamoto</surname><given-names>N</given-names></string-name>. <article-title>Perichromosomal protein Ki67 supports mitotic chromosome architecture</article-title>. <source>Genes Cells</source>. <year>2016</year>;<volume>21</volume>:<fpage>1113</fpage>&#8211;<lpage>24</lpage>.<pub-id pub-id-type="pmid">27610954</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/gtc.12420</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0018"><string-name name-style="western"><surname>Cuylen&#8208;Haering</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Petrovic</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hernandez&#8208;Armendariz</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Schneider</surname><given-names>MWG</given-names></string-name>, <string-name name-style="western"><surname>Samwer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Blaukopf</surname><given-names>C</given-names></string-name>, et al. <article-title>Chromosome clustering by Ki&#8208;67 excludes cytoplasm during nuclear assembly</article-title>. <source>Nature</source>. <year>2020</year>;<volume>587</volume>:<fpage>285</fpage>&#8211;<lpage>90</lpage>.<pub-id pub-id-type="pmid">32879492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-020-2672-3</pub-id><pub-id pub-id-type="pmcid">PMC7666080</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0019"><string-name name-style="western"><surname>Simonetti</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Natalini</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Folgori</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Capone</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Nicosia</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Santoni</surname><given-names>A</given-names></string-name>, et al. <article-title>Antigen&#8208;specific CD8 T cells in cell cycle circulate in the blood after vaccination</article-title>. <source>Scand J Immunol</source>. <year>2019</year>;<volume>89</volume>:<fpage>e12735</fpage>.<pub-id pub-id-type="pmid">30488973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/sji.12735</pub-id><pub-id pub-id-type="pmcid">PMC6850756</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0020"><string-name name-style="western"><surname>Mu&#241;oz&#8208;Ruiz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Pujol&#8208;Autonell</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Rhys</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Long</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Greco</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Peakman</surname><given-names>M</given-names></string-name>, et al. <article-title>Tracking immunodynamics by identification of S&#8208;G<sub>2</sub>/M&#8208;phase T cells in human peripheral blood</article-title>. <source>J Autoimmun</source>. <year>2020</year>;<volume>112</volume>:<elocation-id>102466</elocation-id>.<pub-id pub-id-type="pmid">32414606</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaut.2020.102466</pub-id><pub-id pub-id-type="pmcid">PMC7527781</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0021"><string-name name-style="western"><surname>Ernst</surname><given-names>DN</given-names></string-name>, <string-name name-style="western"><surname>Hobbs</surname><given-names>MV</given-names></string-name>, <string-name name-style="western"><surname>Torbett</surname><given-names>BE</given-names></string-name>, <string-name name-style="western"><surname>Glasebrook</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Rehse</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Bottomly</surname><given-names>K</given-names></string-name>, et al. <article-title>Differences in the expression profiles of CD45RB, Pgp&#8208;1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice</article-title>. <source>J Immunol</source>. <year>1990</year>;<volume>145</volume>:<fpage>1295</fpage>&#8211;<lpage>302</lpage>.<pub-id pub-id-type="pmid">1974562</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0022"><string-name name-style="western"><surname>Pinchuk</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Filipov</surname><given-names>NM</given-names></string-name>. <article-title>Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice</article-title>. <source>Immun Ageing</source>. <year>2008</year>;<volume>5</volume>:<fpage>1</fpage>.<pub-id pub-id-type="pmid">18267021</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1742-4933-5-1</pub-id><pub-id pub-id-type="pmcid">PMC2268915</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0023"><string-name name-style="western"><surname>Clambey</surname><given-names>ET</given-names></string-name>, <string-name name-style="western"><surname>White</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kappler</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Marrack</surname><given-names>P</given-names></string-name>. <article-title>Identification of two major types of age&#8208;associated CD8 clonal expansions with highly divergent properties</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2008</year>;<volume>105</volume>:<fpage>12997</fpage>&#8211;<lpage>3002</lpage>.<pub-id pub-id-type="pmid">18728183</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0805465105</pub-id><pub-id pub-id-type="pmcid">PMC2525558</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0024"><string-name name-style="western"><surname>King</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ilic</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Koelsch</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Sarvetnick</surname><given-names>N</given-names></string-name>. <article-title>Homeostatic expansion of T cells during immune insufficiency generates autoimmunity</article-title>. <source>Cell</source>. <year>2004</year>;<volume>117</volume>:<fpage>265</fpage>&#8211;<lpage>77</lpage>.<pub-id pub-id-type="pmid">15084263</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0092-8674(04)00335-6</pub-id></mixed-citation></ref><ref id="cytoa24509-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cytoa24509-cit-0025"><string-name name-style="western"><surname>Levine</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Arvey</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jin</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Rudensky</surname><given-names>AY</given-names></string-name>. <article-title>Continuous requirement for the TCR in regulatory T cell function</article-title>. <source>Nat Immunol</source>. <year>2014</year>;<volume>15</volume>:<fpage>1070</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">25263123</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3004</pub-id><pub-id pub-id-type="pmcid">PMC4205268</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>